Drs. Giulia Cattaneo & Katie E. McCallum on Feline enteropathogens and molecular diagnostics: benefits limitations, and clinical applications


All Cats Considered – Episode 308

Dr. Giulia Cattaneo, VetMB, MRCVS, and Dr. Katie E. McCallum, BVM&S, PGCertSAM, DipECVIM-CA, AFHEA, MRCVS, join All Cats Considered to discuss their recent review on feline enteropathogens and the clinical use of molecular diagnostics. This episode explores how diagnostic testing can be applied effectively in practice, highlighting when testing is appropriate, how to interpret results, and the challenges of distinguishing causality from incidental findings.

The discussion covers the influence of factors such as age, breed, diet, and environment on disease risk, and examines the strengths and limitations of PCR testing. Drs. Cattaneo and McCallum also address the importance of antibiotic stewardship, the potential role of probiotics and diet trials, and emerging therapies like fecal microbiota transplantation. Their insights offer practical guidance for veterinary professionals navigating the complexities of feline gastrointestinal disease.

Additional Resources:

JFMS Clinical Spotlight article: Feline enteropathogens and molecular diagnostics: benefits, limitations and clinical applications